![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 MARUHA NICHIRO CORPORATION Utsunomiya JP (1)
01 Sodium hyaluronate, Intrinsic viscosity: 1.62m3/kg - 1.70m3/kg and 2.28m3/kg - 3.78m3/kg; from fermentation; for parenteral administration, including intra-articular administration and intra-ocular use (1)
01 U.S.A (1)
01 Valid (1)
20
Maruha Nichiro Corporation Utsunomiya Jp, based in U.S.A, is a pharmaceutical company.
One of their significant offerings is Sodium hyaluronate, Intrinsic viscosity: 1.62m3/kg - 1.70m3/kg and 2.28m3/kg - 3.78m3/kg; from fermentation; for parenteral administration, including intra-articular administration and intra-ocular use, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-242 - Rev 01
This Chemical Type CEP, issued on August 06, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1472 associated with this CEP further emphasizes